Dr Agarwals Eye Hospital Limited

For FY26 (year ended 31 Mar 2026), Dr Agarwals Eye Hospital Limited reported revenue of Rs 471 Cr and net profit of Rs 70.1 Cr, with a net margin of 14.89% and earnings per share of Rs 147.02 (standalone statements).

Year-on-year change: revenue +18.51%; net profit +28.27%; EPS +26.44%. Three-year compound annual growth rate: revenue +20.91%; net profit +23.82%.

At the same date the balance sheet shows total assets of Rs 766 Cr, shareholders' equity of Rs 346 Cr, total debt of Rs 81.8 Cr, cash of Rs 6.6 Cr, a debt-to-equity ratio of 0.24 and operating cash flow of Rs 145 Cr.

On a trailing-twelve-month basis the filings add up to revenue of Rs 497 Cr, net income of Rs 76.2 Cr and a net margin of 15.34%.

In the shareholding pattern for 30 Sept 2026, Dr Agarwals Eye Hospital Limited's ownership is split: promoters 72.67%; foreign institutional investors (FIIs) 2.22%; domestic institutional investors (DIIs) 2.54%; retail and other shareholders 22.57%.

Compared with the filing for 30 Jun 2026: promoter holding 0.00 percentage points; FII holding −0.02 percentage points; DII holding +0.49 percentage points.

The same filing lists reported promoter pledge of 0.00% and 21,392 shareholders on record.

47 BSE corporate announcements were filed by Dr Agarwals Eye Hospital Limited in the past twelve months; the most frequent category is "Company Update" (24). The most recent is "Copy of the communication sent to equity shareholders intimating the fixation of record date is submitted." (Company Update), filed on 27 Oct 2026.

The disclosed corporate-action timeline lists 8 entries: dividend (8). The latest is a dividend (Final Dividend - Rs. - 4.0000) with ex-date 2 Sept 2026.